Ingredients supplier Bioiberica has revamped the brand identity for its healthcare ingredients portfolio as part of the company’s long-term growth strategy.
Ingredients supplier Bioiberica (Barcelona) has revamped the brand identity for its healthcare ingredients portfolio as part of the company’s long-term growth strategy.
Some of the company’s branded ingredients now have new names. b-2Cool, the company’s native, undenatured type II collagen for joint health, has been renamed Collavant n2. The firm’s tendon-health ingredient is called Tendaxion. Other ingredients in the portfolio include patented hyaluronic acid matrix ingredient Mobilee, as well as chondroitin sulfate ingredient CSbioactive. The company’s healthcare portfolio brand identity has also been refreshed.
“The rebrand gives customers a suite of well-defined products, made more accessible and identifiable with a clearer brand architecture,” said Jaume Reguant, Bioiberica’s director of healthcare, in a press release. He continued, “Our newly launched brand strategy for our healthcare-oriented ingredients is designed to deliver enhanced co-collaboration opportunities and a stronger foundation on which to build and market products, providing greater potential for growth in new areas—not just for Bioiberica, but our partners, too.”